Characterization of Retinal Leukostasis and Hemodynamics in Insulin Resistance and Diabetes

Role of Oxidants and Protein Kinase-C Activation

  1. Toru Abiko1,
  2. Atsuko Abiko1,
  3. Allen C. Clermont2,
  4. Brett Shoelson2,
  5. Naoichi Horio1,
  6. Junichi Takahashi1,
  7. Anthony P. Adamis3,
  8. George L. King14 and
  9. Sven-Erik Bursell25
  1. 1Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts
  2. 2Beetham Eye Institute, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts
  3. 3Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  4. 4Department of Medicine, Harvard Medical School, Boston, Massachusetts
  5. 5Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts

    Abstract

    Increases in leukostasis/monocyte adhesion to the capillary endothelium (leukostasis) and decreases in retinal blood flow may be causally associated and are implicated in the pathogenesis of diabetic retinopathy. In this study, we demonstrate that increases in leukostasis are observed in insulin-resistant states without diabetes, whereas decreases in retinal blood flow require diabetes and hyperglycemia. Microimpaction studies using beads mimicking retinal capillary obstruction by leukocytes did not affect retinal blood flow. In diabetic rats, treatment with the antioxidant α-lipoic acid normalized the amount of leukostasis but not retinal blood flow. In contrast, treatment with d-α-tocopherol and protein kinase-C β-isoform inhibition (LY333531) prevented the increases in leukostasis and decreases in retinal blood flow in diabetic rats. Serum hydroxyperoxide, a marker of oxidative stress, was increased in diabetic rats, but normalized by treatment with antioxidants α-lipoic acid and d-α-tocopherol and, surprisingly, PKC β-isoform inhibition. These findings suggest that leukostasis is associated with endothelial dysfunction, insulin resistance, and oxidative stress but is not related to retinal blood flow and is not sufficient to cause diabetic-like retinopathy. Moreover, treatment with PKC β inhibition is effective to normalize diabetes or hyperglycemia-induced PKC β-isoform activation and oxidative stress.

    Footnotes

    • Address correspondence and reprint requests to George L. King, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215. E-mail: george.king{at}joslin.harvard.edu.

      Received for publication 2 July 2002 and accepted in revised form 3 December 2002.

      G.L.K. has received consulting fees from Elli Lilly.

      AOLF, acridine orange leukocyte fluorography; AT, appearance time; ET-1, endothelin-1; MCT, mean circulation time; PKC, protein kinase C; SLO, scanning laser ophthalmoscope; STZ, streptozotocin; VFA, video fluorescein angiography.

    « Previous | Next Article »Table of Contents